Artículos de revistas
Biochemical, Pharmacological And Structural Characterization Of Two Pla2 Isoforms Cdr-12 And Cdr-13 From Crotalus Durissus Ruruima Snake Venom
Registro en:
Protein Journal. , v. 26, n. 1, p. 39 - 49, 2007.
15723887
10.1007/s10930-006-9042-3
2-s2.0-33847113986
Autor
Ponce-Soto L.A.
Baldasso P.A.
Romero-Vargas F.F.
Winck F.V.
Novello J.C.
Marangoni S.
Institución
Resumen
Cdr-12 and Cdr-13 isoforms of PLA2, a D49 protein, were purified from Crotalus durissus ruruima venom after one chromatographic step, reverse phase HPLC on μ-Bondapack C-18. The molecular mass by SDS-PAGE of Cdr-12 and Cdr-13 isoforms of PLA2 was 14333.49 Da and 14296.42 Da, respectively and confirmed by MALDI-TOF mass spectrometry .The amino acid composition showed that both isoforms Cdr-12 and Cdr-13 have a high content of Lys, Tyr, Gly, Arg, and 14 half-Cys residues, typical of a basic PLA2. The isoforms Cdr-12 and Cdr-13 had a sequence of amino acids of 122 amino acid residues, being Cdr-12: SLLQFNKMIK FETRKNAIPF YAFYGCYCGW GGQGRPKDAT DRCCIVHDCC YGKLAKCNTK WDFYRYSLRS GYFQCGKGTW CEQQICECDR VAAECLRRSL STYRYGYMIY PDSRCREPSE TC and pI value 8.37 and Cdr-13: SLVQFEKMIK EETGKNAVPF YAFYGCYCGW GGRGRPKDAT DRCCIVHDCC YEKLVKCNTK WDFYRYSLRS GYFQCGKGTW CEQQICECDR VAAECLRRSL STYRYGKMIY PDSRCREPSE TC with a pI value of 8.13 This sequence shows high identity values when compared to other D49 PLA2s isolated from venoms of crotalics snakes. Skeletal muscle preparations from the young chicken have been previously used in order to study the effects of toxins on neuromuscular transmission, providing an important opportunity to study the differentiated behavior of a toxin before more than one model, because it shows differences in its sensibilities. In mice, the PLA2 isoforms Cdr-12 and Cdr-13 induced myonecrosis and edema, upon intramuscular or subcutaneous injections, respectively. In vitro, Cdr-12 and Cdr-13 isoforms of PLA2, caused a potent blockade of neuromuscular transmission in young chicken biventer cervicis preparation and produced cytotoxicity in murine C2C12 skeletal muscle myotubes and lack cytolytic activity upon myoblasts in vitro. Thus, the combined structural and functional information obtained identify Cdr-12 and Cdr-13 isoforms as members of the PLA2 family, which presents the typical bioactivities described for such proteins. © 2007 Springer Science+Business Media, LLC. 26 1 39 49 Aird, S.D., Kaiser, I.I., Lewis, R.V., Kruggel, W.G., (1986) Arch. Biochem. Biophys, 249, pp. 296-300 Aird, S.D., Kruggel, W.G., Kaiser, I.I., (1990) Toxicon, 28, pp. 669-673 Angulo, Y., Lomonte, B., (2005) Cell Biochem. Funct, 18, pp. 307-313 Araújo, F. A. A., SantaLúcia, M., and Cabral, R. F. (2003). Animais Peçonhentos no Brasil. In J. L. C. Cardoso, F. O. S. França, H. W. Fan, C. M. S. Málaque & V. Haddad Jr. (Eds.), Animais Peçonhentos no Brasil (pp. 6-12). São Paulo: Biologia, Clínica e Terapêutica dos Acidentes Sarvier/FAPESPArni, R.K., Ward, R.J., (1996) Toxicon, 34, pp. 827-841. , Review Azevedo-Marques, M. M., Hering, S. E., and Cupo, P. (2003). Acidente Crotálico, Animais Peçonhentos no Brasil. Biologia, Clínica e Terapêutica dos Acidentes. In J. L. C. Cardoso, F. O. S. França, H. W. Fan, C. M. S. Málaque & V. Haddad Jr. (Eds.), Animais Peçonhentos no Brasil. Biologia, Clínica e Terapêutica dos Acidentes (pp. 91-98). São Paulo: Sarvier/FAPESPBeghini, D.G., Toyama, M.H., Hyslop, S., Sodek, L., Novello, J.C., Marangoni, S., (2000) J. Protein Chem, 19, pp. 603-607 Beghini, D.G., Hernandez-Oliveira, S., Rodrigues-Simioni, L., Novello, J.C., Hyslop, S., Marangoni, S., (2004) Toxicon, 44, pp. 141-148 Beghini, D.G., Rodrigues-Simioni, L., Toyama, M.H., Novello, J.C., da Cruz-Höfling, M.A., Marangoni, S., (2004) Toxicon, 43, pp. 255-261 Bon, C., Bouchier, C., Choumet, V., Faure, G., Jiang, M.S., Lambezat, M.P., Radvanyi, F., Saliou, B., (1989) Acta Physiol. Pharmacol. Latinoam, 39, pp. 439-448 Chijiwa, T., Hamai, S., Tsubouchi, S., Ogawa, T., Deshimaru, M., Oda-Ueda, N., Hattori, S., Ohno, M., (2003) J. Mol. Evol, 57, pp. 546-554 Cho, W., Kézdy, F.J., (1991) Methods Enzymol, 197, pp. 75-79 Choumet, V., Bouchier, C., Delot, E., Faure, G., Saliou, B., Bon, C., (1996) Adv. Exp. Med. Biol, 391, pp. 197-202 Curin-Serbec, V., Novak, D., Babnik, J., Turk, D., Gubensek, F., (1991) FEBS Lett, 280 (1), pp. 175-178 Emmanuel, V., Gérard, L., (2000) Biochimie, 82, pp. 815-831 Faure, G., Bon, C., (1987) Toxicon, 25, pp. 229-234 Faure, G., Bon, C., (1988) Biochemistry, 27, pp. 730-738 Faure, G., Choumet, V., Bouchier, C., Camoin, L., Guillaume, J.L., Monegier, B., Vuilhorgne, M., Bon, C., (1994) Eur. J. Biochem, 223, pp. 161-164 Faure, G., Guillaume, J.L., Camoin, L., Saliou, B., Bon, C., (1991) Biochemistry, 30, pp. 8074-8083 Faure, G., Harvey, A.L., Thomson, E., Saliou, B., Radvanyi, F., Bon, C., (1993) Eur J Biochem, 214, pp. 491-496 Ginsborg, B.L., Warriner, J., (1960) Br. J. Pharmacol, 15, pp. 410-421 Gutiérrez, J.M., Ownby, C.L., (2003) Toxicon, 42, pp. 915-931 Habermann, E., Breithaupt, H., (1978) Toxicon, 16, pp. 19-30 Heinrikson, R.L., Meredith, S.C., (1984) Anal. Biochem, 13, pp. 65-72 Hendon, R.A., Fraenkel-Conrat, H., (1971) Proc. Natl. Acad. Sci. USA, 68, pp. 1560-1563 Hodgson, W.C., Wickramaratna, J.C., (2002) Clin. Exp. Pharmacol. Physiol, 29, pp. 807-814 Holzer, M., Mackessy, S.P., (1996) Toxicon, 34, pp. 1149-1155 Kaiser, I.I., Gutierrez, J.M., Plummer, D., Aird, S.D., Odell, G.V., (1990) Arch. Biochem. Biophys, 278, pp. 319-325 Kini, R.M., (2003) Toxicon, 42, pp. 827-840 Kini, R.M., Evans, H.J., (1989) Int. J. Pept. Protein Res, 34, pp. 277-286 Kini, R.M., Evans, H.J., (1989) Toxicon, 27, pp. 613-635 Kini, R.M., Evans, H.J., (1989) Biochemistry, 28, pp. 9209-9215 Kini, R.M., Iwanaga, S., (1986) Toxicon, 24, pp. 527-541 Kini, R.M., Iwanaga, S., (1986) Toxicon, 24, pp. 895-905 Kini, R.M., Evans, H.J., (1987) J. Biol. Chem, 262, pp. 14402-14407 Kondo, K., Zhang, J., Xu, K., Kagamiyama, H., (1989) J. Biochem, 105, pp. 196-203 Kordis, D., Gubensek, F., (1997) Eur. J. Biochem, 246, pp. 772-779 Krizaj, I., Turk, D., Ritonja, A., Gubensek, F., (1989) Biochim. Biophys. Acta, 30, pp. 198-202 Lennon, B.W., Kaiser, I.I., (1990) Comp. Biochem. Physiol. B, 97, pp. 695-699 Lomonte, B., Angulo, Y., Santamaria, C., (2003) Toxicon, 42, pp. 307-312 Lomonte, B., Pizarro-Cerda, J., Angulo, Y., Gorvel, J.P., Moreno, E., (1999) Biochim. Biophys. Acta, 9, pp. 19-26 Moura-da-Silva, A.M., Paine, M.J., Diniz, M.R., Theakston, R.D., Crampton, J.M., (1995) J. Mol. Evol, 41, pp. 174-179 Oliveira, D.G., Toyama, M.H., Novello, J.C., Beriam, L.O., Marangoni, S., (2002) J. Protein Chem, 21, pp. 161-168 Ponce-Soto, L.A., Toyama, M.H., Hyslop, S., Novello, J.C., Marangoni, S., (2002) J. Protein Chem, 21, pp. 131-136 Ponce-Soto, L.A., Bonfim, V.L., Rodrigues-Simioni, L., Novello, J.C., Marangoni, S., (2006) Protein J, 25, pp. 147-155 Prijatelj, P., Sribar, J., Ivanovski, G., Krizaj, I., Gubensek, F., Pungercar, J., (2003) Eur. J. Biochem, 270, pp. 3018-3025 Rangel-Santos, A., Dos-Santos, E.C., Lopes-Ferreira, M., Lima, C., Cardoso, D.F., Mota, I., (2004) Toxicon, 43, pp. 801-810 Six, D.A., Dennis, E.A., (2000) Biochim Biophys Acta, 1488, pp. 1-19 Slotboom, A.J., de Haas, G.H., (1975) Biochemistry, 16, pp. 5394-5399 Tsai, I. H., Lu, P. J., Wang, Y. M., Ho, C. L., and Liaw, L. L (1995). Biochem. J. 311:(PT 3), 895-900